Cargando...
Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
Glioblastoma (GBM) is a highly malignant and aggressive primary brain tumor mostly prevalent in adults and is associated with a very poor prognosis. Moreover, only a few effective treatment regimens are available due to their rapid invasion of the brain parenchyma and resistance to conventional ther...
Gardado en:
| Publicado en: | Front Immunol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734213/ https://ncbi.nlm.nih.gov/pubmed/33329578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.592612 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|